#Gene-editing

[ follow ]
#neuroscience
Nature
1 day ago
OMG science

Daily briefing: How to win a Nobel prize: what past winners can tell you about your chances

New Îł-ray radiation linked to thunderstorms may explain lightning initiation.
Gene editing rejuvenates brain stem cells in ageing mice, hinting at potential therapies.
White noise boosts growth in fungal microbes, altering their genetic expression. [ more ]
Inverse
1 day ago
OMG science

A Novel Discovery Hints At Why We Stop Producing New Brain Cells - And What We Can Do About It

Neural stem cells' decline with age can be linked to glucose levels, highlighting a potential pathway for combating cognitive decline. [ more ]
Nature
2 days ago
OMG science

CRISPR helps brain stem cells regain youth in mice

Disabling a specific metabolism-related gene can rejuvenate neural stem cells, enhancing their ability to produce new neurons as organisms age. [ more ]
Nature
1 day ago
OMG science

Daily briefing: How to win a Nobel prize: what past winners can tell you about your chances

New Îł-ray radiation linked to thunderstorms may explain lightning initiation.
Gene editing rejuvenates brain stem cells in ageing mice, hinting at potential therapies.
White noise boosts growth in fungal microbes, altering their genetic expression. [ more ]
Inverse
1 day ago
OMG science

A Novel Discovery Hints At Why We Stop Producing New Brain Cells - And What We Can Do About It

Neural stem cells' decline with age can be linked to glucose levels, highlighting a potential pathway for combating cognitive decline. [ more ]
Nature
2 days ago
OMG science

CRISPR helps brain stem cells regain youth in mice

Disabling a specific metabolism-related gene can rejuvenate neural stem cells, enhancing their ability to produce new neurons as organisms age. [ more ]
moreneuroscience
#gene-editing
Fast Company
3 weeks ago
OMG science

Why Jennifer Doudna is one of Fast Company's 10 most innovative people of the last 10 years

CRISPR technology has revolutionized gene editing in medicine, impacting various diseases and treatment methodologies. [ more ]
24/7 Wall St.
3 weeks ago
Startup companies

2 Biotech Bets to Buy in September

Biotech investing offers both high rewards and significant risks, necessitating resilience and a long-term commitment from investors. [ more ]
Nature
1 month ago
OMG science

Daily briefing: How long can we hold off more controversial 'CRISPR babies'?

Gene editing of babies is being considered by some scientists despite ongoing controversies.
Research indicates that environmental factors significantly impact brain ageing, particularly in socio-economically disadvantaged regions.
The Oropouche virus is expanding its range, raising public health concerns due to recent fatalities. [ more ]
Inverse
1 month ago
OMG science

Designer Babies Are Here - So Why Aren't We Talking About It?

Scientists often overlook the societal implications of their research due to a lack of training and incentives. [ more ]
Boston.com
2 months ago
US news

A disease that makes children age rapidly gets closer to a cure

Gene editing may offer hope for treating ultrarare conditions like progeria, potentially paving the way for treatments for other genetic diseases. [ more ]
www.nytimes.com
2 months ago
OMG science

A Disease That Makes Children Age Rapidly Gets Closer to a Cure

A cure for progeria through gene editing may be imminent. [ more ]
Fast Company
3 weeks ago
OMG science

Why Jennifer Doudna is one of Fast Company's 10 most innovative people of the last 10 years

CRISPR technology has revolutionized gene editing in medicine, impacting various diseases and treatment methodologies. [ more ]
24/7 Wall St.
3 weeks ago
Startup companies

2 Biotech Bets to Buy in September

Biotech investing offers both high rewards and significant risks, necessitating resilience and a long-term commitment from investors. [ more ]
Nature
1 month ago
OMG science

Daily briefing: How long can we hold off more controversial 'CRISPR babies'?

Gene editing of babies is being considered by some scientists despite ongoing controversies.
Research indicates that environmental factors significantly impact brain ageing, particularly in socio-economically disadvantaged regions.
The Oropouche virus is expanding its range, raising public health concerns due to recent fatalities. [ more ]
Inverse
1 month ago
OMG science

Designer Babies Are Here - So Why Aren't We Talking About It?

Scientists often overlook the societal implications of their research due to a lack of training and incentives. [ more ]
Boston.com
2 months ago
US news

A disease that makes children age rapidly gets closer to a cure

Gene editing may offer hope for treating ultrarare conditions like progeria, potentially paving the way for treatments for other genetic diseases. [ more ]
www.nytimes.com
2 months ago
OMG science

A Disease That Makes Children Age Rapidly Gets Closer to a Cure

A cure for progeria through gene editing may be imminent. [ more ]
moregene-editing
www.npr.org
9 months ago
Science

FDA approves first gene-editing treatments for human illness

The FDA has approved the first gene-editing treatments for sickle cell disease, marking a milestone in the field of gene-editing.
The treatments have the potential to provide more targeted and effective treatments for rare diseases with limited current options. [ more ]
www.nytimes.com
9 months ago
Health

F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR

The Food and Drug Administration has approved the first gene editing therapy and conventional gene therapy for sickle cell disease.
Obstacles to treatment include limited access to authorized medical centers, individualized procedures, and high costs. [ more ]
The Atlantic
10 months ago
Medicine

The CRISPR Era Is Here

Gene-editing technology CRISPR has successfully treated a patient with sickle-cell disease, providing hope for future treatments.
The treatment resulted in the patient living virtually symptom-free, with 29 out of 30 eligible patients experiencing zero pain crises after treatment. [ more ]
#gene editing
www.fastcompany.com
10 months ago
Health

The U.K. approved its first CRISPR gene-editing drugand the U.S. is expected to follow

U.K. regulators have approved the first-ever CRISPR gene-editing drug for the treatment of sickle cell disease and beta thalassemia.
The therapy has shown success in clinical trials and is expected to reach the U.S. by the end of the year.
The gene editing treatment modifies stem cells to boost the production of functional hemoglobin, providing a fix at the DNA level. [ more ]
Engadget
10 months ago
Medicine

UK authorizes first gene therapy for treating sickle cell disease

The UK's MHRA has approved the use of a gene-editing therapy for patients with sickle cell disease and beta thalassemia.
The therapy, called Casgevy, is the first-ever approved therapy that uses CRISPR-based gene editing technology.
The therapy has shown high efficacy in relieving severe pain associated with these blood disorders and could potentially replace the current standard of care. [ more ]
Ars Technica
10 months ago
Health

Crispr gene editing shown to permanently lower high cholesterol

Researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol in a small test on people.
The gene-editing treatment aims to permanently lower cholesterol by using Crispr to edit a gene in the liver.
Preliminary results of the experiment were presented at the American Heart Association's annual meeting. [ more ]
WIRED
10 months ago
Medicine

A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol

Researchers have shown that a single infusion of a gene-editing treatment can reduce cholesterol levels in people.
The treatment aims to permanently lower cholesterol by using Crispr to edit a gene in the liver, and initial results show significant reductions in LDL cholesterol.
Gene editing could provide a lasting option for treating hereditary high cholesterol, replacing the need for long-term medication. [ more ]
Inverse
10 months ago
Health

Goodbye Statins? New Gene Editing Therapy Slashes High Cholesterol

A novel gene editing therapy using base editing lowered "bad" cholesterol levels in individuals with FH by as much as 55 percent.
The therapy could potentially provide a single-course treatment option for deep LDL lowering for decades without the need for daily pills or intermittent injections. [ more ]
www.nytimes.com
10 months ago
Health

New Gene Editing Treatment Cuts Dangerous Cholesterol in Small Study

Gene editing treatment shows promise in lowering cholesterol levels in patients with severe heart disease
Treatment has the potential to transform preventive cardiology [ more ]
www.fastcompany.com
10 months ago
Health

The U.K. approved its first CRISPR gene-editing drugand the U.S. is expected to follow

U.K. regulators have approved the first-ever CRISPR gene-editing drug for the treatment of sickle cell disease and beta thalassemia.
The therapy has shown success in clinical trials and is expected to reach the U.S. by the end of the year.
The gene editing treatment modifies stem cells to boost the production of functional hemoglobin, providing a fix at the DNA level. [ more ]
Engadget
10 months ago
Medicine

UK authorizes first gene therapy for treating sickle cell disease

The UK's MHRA has approved the use of a gene-editing therapy for patients with sickle cell disease and beta thalassemia.
The therapy, called Casgevy, is the first-ever approved therapy that uses CRISPR-based gene editing technology.
The therapy has shown high efficacy in relieving severe pain associated with these blood disorders and could potentially replace the current standard of care. [ more ]
Ars Technica
10 months ago
Health

Crispr gene editing shown to permanently lower high cholesterol

Researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol in a small test on people.
The gene-editing treatment aims to permanently lower cholesterol by using Crispr to edit a gene in the liver.
Preliminary results of the experiment were presented at the American Heart Association's annual meeting. [ more ]
WIRED
10 months ago
Medicine

A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol

Researchers have shown that a single infusion of a gene-editing treatment can reduce cholesterol levels in people.
The treatment aims to permanently lower cholesterol by using Crispr to edit a gene in the liver, and initial results show significant reductions in LDL cholesterol.
Gene editing could provide a lasting option for treating hereditary high cholesterol, replacing the need for long-term medication. [ more ]
Inverse
10 months ago
Health

Goodbye Statins? New Gene Editing Therapy Slashes High Cholesterol

A novel gene editing therapy using base editing lowered "bad" cholesterol levels in individuals with FH by as much as 55 percent.
The therapy could potentially provide a single-course treatment option for deep LDL lowering for decades without the need for daily pills or intermittent injections. [ more ]
www.nytimes.com
10 months ago
Health

New Gene Editing Treatment Cuts Dangerous Cholesterol in Small Study

Gene editing treatment shows promise in lowering cholesterol levels in patients with severe heart disease
Treatment has the potential to transform preventive cardiology [ more ]
moregene editing
MedCity News
10 months ago
Medicine

U.K. Is First to Approve a CRISPR-Based Therapy, Covering Two Blood Disorders

The UK has authorized a gene-editing medicine for treating sickle cell disease and beta thalassemia, marking the first approval worldwide for a therapy based on CRISPR technology.
The therapy, known as Casgevy, involves editing a gene in a patient's stem cells to produce high levels of fetal hemoglobin.
Casgevy offers a potentially curative treatment option for these inherited blood disorders, reducing the need for chronic therapies and blood transfusions. [ more ]
www.nytimes.com
10 months ago
Health

Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval

Regulators in Britain have approved the first treatment derived from CRISPR, called Casgevy, for sickle-cell disease and beta thalassemia.
About 2,000 patients in Britain are expected to be eligible for Casgevy treatment.
The FDA is expected to approve Casgevy for sickle-cell patients in the US in early December. [ more ]
www.npr.org
10 months ago
Health

For the first time, gene-editing provides hints for lowering cholesterol

Preliminary results show that gene-editing can reduce high cholesterol levels in patients with a genetic condition.
More research is needed to confirm the safety and effectiveness of the treatment.
This could potentially provide a new way to prevent heart attacks and strokes. [ more ]
[ Load more ]